NCT05209100View on ClinicalTrials.gov

Microbiome-Mediated Gut Dysfunction in Non-Alcoholic Fatty Liver Disease

Active, not recruitingOBSERVATIONAL
Enrollment

38

Participants

Timeline

Start Date

February 11, 2022

Primary Completion Date

March 22, 2023

Study Completion Date

December 31, 2025

Conditions
Non-Alcoholic Fatty Liver Disease
Interventions
PROCEDURE

Sigmoidoscopy

During the sigmoidoscopy, biopsy tissue will be obtained for research purposes. Biopsies will be performed based on typical standard of care procedures without an antecedent bowel prep.

Trial Locations (1)

32804

AdventHealth Translational Research Institute, Orlando

All Listed Sponsors
lead

AdventHealth Translational Research Institute

OTHER